Journal of Clinical Endocrinology & Metabolism, Vol 76, 715-720, Copyright © 1993 by Endocrine Society

ARTICLES

Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism

S Khosla, PR Ebeling, AF Firek, MM Burritt, PC Kao and H Heath 3d
Division of Endocrinology, Metabolism, and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.

PTH clearly plays a role in maintaining the hypercalcemia of familial benign hypercalcemia (FBH or familial hypocalciuric hypocalcemia). To better define the abnormalities of parathyroid function in FBH and primary hyperparathyroidism (1 degree HPT), we used a two-site immunochemiluminometric assay for intact PTH to examine PTH suppressibility in normal individuals and patients having FBH or 1 degree HPT. Twelve normal, 11 FBH, and 7 1 degree HPT subjects were given calcium (Ca) iv with frequent sampling for ionized Ca and intact PTH. In normal and FBH subjects, plasma PTH levels decreased essentially identically in response to iv Ca. In the 1 degree HPT group, PTH was not normally suppressible. However, there was a spectrum of responsiveness in 1 degree HPT patients, with a significant correlation between tumor mass and degree of PTH nonsuppressibility (r = 0.87, P = 0.01). Analysis of the relationship between plasma PTH and ionized Ca values in the three groups demonstrated a shift to the right in the FBH curve, with no difference of slope, consistent with the notion of a simple "set-point" error in FBH. In contrast, the curve in 1 degree HPT was not only shifted to the right but also differed from normal in slope (normal, -8.92; 1 degree HPT, -3.92, P = 0.04). Thus, we propose that the parathyroid functional abnormality in FBH represents a simple set-point error, whereas the defect in 1 degree HPT consists of a set-point error combined with varying degrees of Ca nonsuppressible PTH secretion that may be related to tumor mass.

This article has been cited by other articles:

				A. L. M. de Francisco, M. Izquierdo, J. Cunningham, C. Pinera, R. Palomar, G. F. Fresnedo, J. A. Amado, M. G. Unzueta, and M. Arias Calcium-mediated parathyroid hormone release changes in patients treated with the calcimimetic agent cinacalcet Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2895 - 2901. [Abstract] [Full Text] [PDF]

				I. Titon, A. Cailleux-Bounacer, J. P. Basuyau, H. Lefebvre, A. Savoure, and J. M. Kuhn Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism Eur. J. Endocrinol., September 1, 2007; 157(3): 351 - 357. [Abstract] [Full Text] [PDF]

				A. M. Ahmad, M. T. Hopkins, J. Thomas, B. H. Durham, W. D. Fraser, and J. P. Vora Parathyroid responsiveness to hypocalcemic and hypercalcemic stimuli in adult growth hormone deficiency after growth hormone replacement Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E986 - E993. [Abstract] [Full Text] [PDF]

				J. F. Raposo, L. G. Sobrinho, and H. G. Ferreira A Minimal Mathematical Model of Calcium Homeostasis J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4330 - 4340. [Abstract] [Full Text] [PDF]

				M. A. Syed, M. J. Horwitz, M. B. Tedesco, A. Garcia-Ocaña, S. R. Wisniewski, and A. F. Stewart Parathyroid Hormone-Related Protein-(1-36) Stimulates Renal Tubular Calcium Reabsorption in Normal Human Volunteers: Implications for the Pathogenesis of Humoral Hypercalcemia of Malignancy J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1525 - 1531. [Abstract] [Full Text]

				F. Cetani, A. Picone, P. Cerrai, E. Vignali, S. Borsari, E. Pardi, P. Viacava, A. G. Naccarato, P. Miccoli, O. Kifor, et al. Parathyroid Expression of Calcium-Sensing Receptor Protein and in Vivo Parathyroid Hormone-Ca2+ Set-Point in Patients with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4789 - 4794. [Abstract] [Full Text]

				F. Malberti, M. Farina, and E. Imbasciati The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2398 - 2406. [Abstract] [Full Text] [PDF]

				S. J. Marx CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3001 - 3009. [Full Text]

				W. G. Goodman, J. D. Veldhuis, T. R. Belin, A. J. Van Herle, H. Juppner, and I. B. Salusky Calcium-Sensing by Parathyroid Glands in Secondary Hyperparathyroidism J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2765 - 2772. [Abstract] [Full Text]

				L. F. Barrett and P. R. Pietromonaco Accuracy of the Five-Factor Model in Predicting Perceptions of Daily Social Interactions Pers Soc Psychol Bull, November 1, 1997; 23(11): 1173 - 1187. [Abstract]

				S. T. Haden, A. L. Stoll, S. McCormick, J. Scott, and G. El-Hajj Fuleihan Alterations in Parathyroid Dynamics in Lithium-Treated Subjects J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2844 - 2848. [Abstract] [Full Text] [PDF]

				E. M. Brown, M. Pollak, C. E. Seidman, J.G. Seidman, Y.-H. W. Chou, D. Riccardi, and S. C. Hebert Calcium-Ion-Sensing Cell-Surface Receptors N. Engl. J. Med., July 27, 1995; 333(4): 234 - 240. [Full Text] [PDF]

				J. E. Garrett, I. V. Capuano, L. G. Hammerland, B. C. P. Hung, E. M. Brown, S. C. Hebert, E. F. Nemeth, and F. Fuller Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAs J. Biol. Chem., May 26, 1995; 270(21): 12919 - 12925. [Abstract] [Full Text] [PDF]